Cite

HARVARD Citation

    Short, N. et al. (2016). The safety and efficacy of vosaroxin in patients with first relapsed or refractory acute myeloid leukemia - a critical review. Expert review of hematology. 9 (6), pp. 529-534. [Online]. 
  
Back to record